Previous Article | Next Article ![]()
Journal of Virology, May 1999, p. 4074-4082, Vol. 73, No. 5
Virology Group,
Received 1 June 1998/Accepted 12 January 1999
Hepatitis E virus (HEV) is the etiological agent for viral
hepatitis type E, which is a major problem in the developing world. Because HEV cannot be cultured in vitro, very little information exists
on the mechanisms of HEV gene expression and genome replication. HEV is
a positive-strand RNA virus with three potential open reading frames
(ORFs), one of which (ORF2) is postulated to encode the major viral
capsid protein (pORF2). We earlier showed (S. Jameel, M. Zafrullah,
M. H. Ozdener, and S. K. Panda, J. Virol. 70:207-216, 1996) pORF2 to be a ~88-kDa glycoprotein, carrying N-linked glycans and a potential endoplasmic reticulum (ER)-directing signal at its N
terminus. Treatment with the drugs brefeldin A and monensin suggest
that the protein may accumulate within the ER. Based on mutational
analysis, we demonstrate Asn-310 to be the major site of N-glycan
addition. In COS-1 cell expression and in vitro translation experiments, we confirm the ER-translocating nature of the pORF2 N-terminal hydrophobic sequence and show that the protein is
cotranslationally, but not posttranslationally, translocated across the
ER membrane. Earlier, we had also demonstrated cell surface
localization of a fraction of the COS-1 cell-expressed pORF2. Using
glycosylation- and translocation-defective mutants of pORF2, we now
show that while transit of pORF2 into the ER is necessary for its cell
surface expression, glycosylation of the protein is not required for
such localization. These results may offer clues to the mechanisms of
gene expression and capsid assembly in HEV.
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Mutational Analysis of Glycosylation, Membrane
Translocation, and Cell Surface Expression of the Hepatitis E Virus
ORF2 Protein

*
Corresponding author. Mailing address: International
Centre for Genetic Engineering and Biotechnology, P.O. Box 10504, Aruna Asaf Ali Marg, New Delhi 110067, India. Phone: 91-11-6176680. Fax:
91-11-6162316. E-mail: shahid{at}icgeb.res.in.
Present address: Department of Medicine, Division of Clinical
Pharmacology, Thomas Jefferson University School of Medicine, Philadelphia, PA.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|